Also trades as: GOVXW (NASDAQ) · $vol 0M
GOVX NASDAQ
GeoVax Labs, Inc.
1W: -6.5%
1M: -40.6%
3M: -73.8%
YTD: -93.7%
1Y: -97.6%
3Y: -99.8%
5Y: -100.0%
$0.32
-0.00 (-0.65%)
Weekly Expected Move ±6.9%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-09-29
Earliest Filing
2023-12-04
Latest Filing
licensee: 2
partner: 2
investor: 1
Counterparties (Filed by GOVX)
5 relationshipsCompanies named in GOVX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Armistice Capital Master Fund Ltd. | — | investor | Holder of Common Stock Purchase Warrants issued by GeoVax Labs, Inc. | 2023-12-04 | View |
| GeoVax, Inc. | GOVX | licensee | Licensee in an exclusive license agreement for COVID-19 vaccine patent rights and materials. | 2021-11-10 | View |
| City of Hope | — | licensee | Licensor granting exclusive rights to its COVID-19 vaccine patent rights and materials. | 2021-11-10 | View |
| GeoVax Labs, Inc. | GOVX | partner | Issuer of the Common Stock Purchase Warrant | 2021-09-29 | View |
| PNP Therapeutics, Inc. | — | partner | Original holder of the Common Stock Purchase Warrant | 2021-09-29 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-10 | Other Events; Exhibits | View | |
| 2026-08-28 | Delisting Notice; Exhibits | View | |
| 2026-08-28 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-07-27 | Earnings Release; Exhibits | View | |
| 2026-07-10 | Delisting Notice | View | |
| 2026-06-17 | Shareholder Vote | View | |
| 2026-05-19 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-05-14 | Earnings Release; Exhibits | View | |
| 2026-05-07 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-04-15 | Earnings Release; Exhibits | View | |
| 2026-03-31 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-02-17 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2026-01-12 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-12-22 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-11-26 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-30 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-08-01 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-07-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-02 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR